Fetal Cardiac Functions in Fasting Pregnant Women
Launched by SANLIURFA EDUCATION AND RESEARCH HOSPITAL · Mar 23, 2025
Trial Information
Current as of July 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Pregnancies at 24-34 weeks of gestation who present to our hospital for routine antenatal follow-up will be evaluated. As the study group, singleton uncomplicated pregnancies with at least 10 days of fasting will be assessed. All ultrasonographic examinations will be conducted within the last 2 hours of the fasting period. The control group will consist of healthy pregnant women who do not fast, with singleton uncomplicated pregnancies between 24-34 weeks, matched for age, parity, and gestational age.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Singleton, uncomplicated pregnancies that have been fasting for at least the last 10 days
- • Present for routine antenatal follow-up between 24-34 weeks of gestation
- Exclusion Criteria:
- • Multiple pregnancy
- • Premature rupture of membranes
- • Chorioamnionitis
- • Placental abruption
- • Severe fetal growth restriction
- • Congenital fetal anomalies
- • Preeclampsia
- • Oligohydramnios
- • Maternal diabetes -Conditions where fasting is contraindicated for the mother. -
About Sanliurfa Education And Research Hospital
Sanliurfa Education and Research Hospital is a leading healthcare institution dedicated to advancing medical knowledge and improving patient outcomes through innovative research. Located in Sanliurfa, Turkey, the hospital combines extensive clinical expertise with a commitment to education, fostering an environment that supports rigorous clinical trials and translational research. As a sponsor of clinical trials, Sanliurfa Education and Research Hospital is focused on exploring novel treatment options and enhancing therapeutic strategies, ensuring adherence to the highest ethical standards and regulatory guidelines. Their multidisciplinary approach integrates cutting-edge methodologies with patient-centered care, ultimately contributing to the global body of medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
şanlıurfa, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported